Health Revenue Assurance Holdings, Inc. (HRAA) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Health Revenue Assurance Holdings, Inc. (HRAA) trades at $0.05 with AI Score 44/100 (Grade C). Health Revenue Assurance Holdings, Inc. provides revenue cycle services to healthcare providers in the United States, including data analysis, coding, and compliance. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for HRAA: HRAA does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HRAA against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
HRAA: the 3 scored disciplines are evenly split. Dominant signal: Seth Klarman bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Health Revenue Assurance Holdings, Inc. (HRAA) Healthcare & Pipeline Overview
Health Revenue Assurance Holdings, Inc. offers revenue cycle management solutions for healthcare providers, focusing on data analysis, coding, and compliance. Operating in the competitive healthcare sector, the company caters to providers seeking to optimize revenue streams and navigate complex regulatory landscapes, but faces challenges given its negative profitability.
What Is the Investment Thesis for HRAA?
Investing in Health Revenue Assurance Holdings, Inc. presents a high-risk, high-reward scenario. The company operates in the growing healthcare revenue cycle management market, but its negative profit margin of -6.9% and a negative P/E ratio of -1.40 indicate significant financial challenges. A potential turnaround hinges on the company's ability to improve operational efficiency and capitalize on growth opportunities within the healthcare sector. The negative beta of -2.34 suggests the stock moves inversely to the market, but this may reflect its financial instability rather than true diversification benefits. Growth catalysts include expanding service offerings and penetrating new geographic markets. However, investors should carefully consider the risks associated with the company's financial performance and OTC market listing.
Based on FMP financials and quantitative analysis
HRAA Key Highlights
Negative P/E ratio of -1.40 indicates the company is currently unprofitable.
- Gross Margin of 13.4% suggests potential for improvement in operational efficiency.
- Negative Profit Margin of -6.9% highlights financial challenges.
- Beta of -2.34 indicates the stock's price is inversely correlated with the market.
- The company operates in the healthcare revenue cycle management market, which is expected to grow.
Who Are HRAA's Competitors?
HRAA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| UNH UnitedHealth Group Incorporated | $387.34 | -0.33% | $352B | 76 |
| CVS CVS Health Corporation | $93.65 | -1.33% | $119B | 70 |
| ANTM Elevance Health Inc. | $482.58 | +2.71% | $115B | 48 |
| ELV Elevance Health Inc. | $397.54 | -0.23% | $86.2B | 86 |
| CI Cigna Corporation | $274.41 | -1.10% | $72.5B | 78 |
| HUM Humana Inc. | $381.21 | +0.84% | $45.8B | 50 |
| CNC Centene Corporation | $64.14 | -0.86% | $31.7B | 65 |
| MOH Molina Healthcare, Inc. | $198.04 | -1.56% | $10.3B | 79 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HRAA's Key Strengths?
Specialized expertise in healthcare revenue cycle management.
- Comprehensive suite of services.
- Established presence in the US market.
What Are HRAA's Weaknesses?
Negative profit margin.
- Small market capitalization.
- OTC market listing.
What Could Drive HRAA Stock Higher?
Potential for strategic partnerships with healthcare systems to drive revenue growth.
- Increasing demand for revenue cycle management services due to evolving regulations.
- Expansion into new geographic markets to broaden client base.
What Are the Key Risks for HRAA?
Intense competition in the healthcare RCM market could limit growth.
- Negative profit margin and financial instability may hinder operations.
- OTC market listing increases volatility and reduces liquidity.
- Changes in healthcare regulations could impact the demand for services.
What Are the Growth Opportunities for HRAA?
- Expansion into Telehealth Billing: The increasing adoption of telehealth services presents a significant growth opportunity for Health Revenue Assurance Holdings, Inc. As telehealth becomes more prevalent, healthcare providers require specialized billing and coding expertise to navigate the unique challenges of remote patient care. By developing expertise in telehealth billing, the company can tap into a rapidly expanding market segment. The telehealth market is projected to reach $55 billion by 2027, offering a substantial revenue opportunity for companies providing related services.
- Strategic Partnerships with Healthcare Systems: Forming strategic partnerships with large healthcare systems can provide Health Revenue Assurance Holdings, Inc. with access to a broader client base and recurring revenue streams. By integrating its services into the workflows of these systems, the company can establish long-term relationships and secure a steady flow of business. This approach can also enhance the company's credibility and reputation within the industry. The healthcare systems market represents a multi-billion dollar opportunity, with potential for significant revenue growth through strategic alliances.
- Development of Proprietary Technology Solutions: Investing in the development of proprietary technology solutions can differentiate Health Revenue Assurance Holdings, Inc. from its competitors and enhance its service offerings. By creating innovative tools for revenue cycle management, the company can improve efficiency, accuracy, and compliance for its clients. This can also lead to increased customer satisfaction and retention. The market for healthcare technology solutions is growing rapidly, driven by the need for improved efficiency and data analytics.
- Geographic Expansion into Underserved Markets: Expanding its geographic footprint into underserved markets can provide Health Revenue Assurance Holdings, Inc. with access to new clients and revenue streams. By targeting regions with limited access to revenue cycle management services, the company can establish a strong presence and capture market share. This approach requires careful market research and strategic planning, but can yield significant long-term benefits. The underserved markets represent a substantial opportunity for companies seeking to expand their reach and impact.
- Focus on Value-Based Care Reimbursement Models: As the healthcare industry shifts towards value-based care reimbursement models, Health Revenue Assurance Holdings, Inc. can capitalize on this trend by developing expertise in these new payment systems. By helping healthcare providers navigate the complexities of value-based care, the company can position itself as a valuable partner and secure a competitive advantage. The transition to value-based care is expected to accelerate in the coming years, creating a growing demand for related services.
What Threats Does HRAA Face?
- Intense competition in the healthcare RCM market.
- Evolving regulations and payer requirements.
- Potential for cybersecurity breaches and data privacy violations.
What Are HRAA's Competitive Advantages?
- Specialized expertise in healthcare revenue cycle management.
- Established relationships with healthcare providers.
- Comprehensive suite of services covering various aspects of the revenue cycle.
What Does HRAA Do?
Health Revenue Assurance Holdings, Inc., founded in 2001 and headquartered in New York City, specializes in providing revenue cycle services to healthcare providers across the United States. The company's core offerings encompass a range of solutions designed to optimize revenue streams and ensure regulatory compliance for its clients. These services include revenue cycle data analysis, contract management, outsourced coding services, and comprehensive billing, coding, and compliance audits. Additionally, Health Revenue Assurance Holdings, Inc. offers coding education, coding consulting, physician coding, and ICD-10 education and transition services. By focusing on these specialized services, the company aims to assist healthcare providers in navigating the complexities of revenue cycle management, allowing them to focus on patient care while ensuring financial stability. The company's suite of services is designed to address the evolving needs of the healthcare industry, particularly in the areas of regulatory compliance and revenue optimization. Health Revenue Assurance Holdings, Inc. positions itself as a partner to healthcare providers, offering expertise and support in managing the financial aspects of their operations.
What Products and Services Does HRAA Offer?
- Provides revenue cycle data analysis to healthcare providers.
- Offers contract management services to optimize revenue streams.
- Provides outsourced coding services to ensure accurate billing.
- Conducts billing, coding, and compliance audits.
- Offers coding education and consulting services.
- Provides physician coding services.
- Offers ICD-10 education and transition services.
How Does HRAA Make Money?
- Provides revenue cycle management services to healthcare providers.
- Generates revenue through fees for services rendered.
- Focuses on improving the financial performance of its clients.
What Industry Does HRAA Operate In?
Health Revenue Assurance Holdings, Inc. operates within the healthcare revenue cycle management (RCM) market. This market is characterized by increasing complexity due to evolving regulations, payer requirements, and technological advancements. Healthcare providers are increasingly seeking external expertise to optimize their revenue cycle processes, driving demand for RCM services. The market is competitive, with a mix of large established players and smaller niche providers. Health Revenue Assurance Holdings, Inc. competes with companies offering similar services, and must differentiate itself through specialized expertise, technology, or customer service. The company's success depends on its ability to adapt to changing industry dynamics and provide value to its clients.
Who Are HRAA's Key Customers?
- Hospitals and healthcare systems.
- Physician practices and clinics.
- Other healthcare providers.
Company Profile
Health Revenue Assurance Holdings, Inc. operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in New York City, US. HRAA has traded publicly since 2012.
HRAA Valuation & Market Position
Relative to its peer group, HRAA's quantitative score of 44/100 is below the peer average of 72/100.
Key Financial Metrics
Return on equity for Health Revenue Assurance Holdings, Inc. stands at 11.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -5.9%, showing how much profit it generates from its asset base. A current ratio of 0.34 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -10.9%, the inverse of the P/E and a quick read on earnings relative to price.
HRAA Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Specialized expertise in healthcare revenue cycle management.
- Comprehensive suite of services.
- Established presence in the US market.
- Upcoming: Potential for strategic partnerships with healthcare systems to drive revenue growth.
Bear Case
- Negative profit margin.
- Small market capitalization.
- OTC market listing.
- Potential: Intense competition in the healthcare RCM market could limit growth.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
HRAA Latest News
No recent news available for HRAA.
HRAA Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HRAA.
Price Targets
Wall Street price target analysis for HRAA.
HRAA MoonshotScore
What does this score mean?
The MoonshotScore rates HRAA 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
HRAA OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Health Revenue Assurance Holdings, Inc. may not meet the minimum financial standards required for higher tiers like OTCQB or OTCQX. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility due to the lack of stringent listing requirements.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Higher potential for fraud and manipulation.
- Lower liquidity and wider bid-ask spreads.
- Greater price volatility.
- Potential for delisting or suspension of trading.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Review the company's risk factors and potential liabilities.
- Consult with a qualified financial advisor.
- Understand the risks associated with investing in OTC stocks.
- Years in operation (founded in 2001).
- Specific business focus (healthcare revenue cycle management).
- Headquarters in New York City.
Common Questions About HRAA (Healthcare)
What does the AI Score mean for HRAA?
HRAA holds an AI Score of 44/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Health Revenue Assurance Holdings, Inc. provides revenue cycle services to healthcare providers in the United States, including data analysis, coding, and compliance. The company operates in …
What does Health Revenue Assurance Holdings, Inc. do?
Health Revenue Assurance Holdings, Inc. specializes in providing revenue cycle management services to healthcare providers in the United States. This includes a range of services such as revenue cycle data analysis, contract management, outsourced coding, billing and compliance audits, and coding education.
What do analysts say about HRAA stock?
As of 2026-03-17, there is no readily available analyst coverage or consensus for Health Revenue Assurance Holdings, Inc. This is likely due to its OTC listing and small market capitalization. Key valuation metrics such as P/E ratio (-1.40) and profit margin (-6.9%) suggest the company is currently facing financial challenges.
What are the main risks for HRAA?
The main risks for Health Revenue Assurance Holdings, Inc. include its negative profit margin, which indicates financial instability. The company also faces intense competition in the healthcare revenue cycle management market. Its OTC market listing increases volatility and reduces liquidity, making it difficult to buy or sell shares. Additionally, changes in healthcare regulations could impact the demand for its services. Investors should carefully consider these risks before investing.
What are the key factors to evaluate for HRAA?
Health Revenue Assurance Holdings, Inc. (HRAA) holds an AI score of 44/100 (low). Investing in Health Revenue Assurance Holdings, Inc. Not financial advice.
How frequently does HRAA data refresh on this page?
HRAA's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven HRAA's recent stock price performance?
Health Revenue Assurance Holdings, Inc. (HRAA) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized expertise in healthcare revenue cycle management. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HRAA overvalued or undervalued right now?
Health Revenue Assurance Holdings, Inc. (HRAA) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research HRAA before investing?
Before investing in Health Revenue Assurance Holdings, Inc. (HRAA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited and subject to inaccuracies.
- AI analysis is pending and may provide additional insights.